Urologist
A patient with suspected renal cell carcinoma should see a urologist first, as this specialist should lead the entire counseling and management process for renal masses. 1, 2
Primary Specialist Role
The AUA guidelines explicitly state that a urologist should lead the counseling process and should consider all management strategies for patients with solid or complex cystic renal masses 1, 2. This recommendation is based on the complexity of renal mass management, which requires expertise in:
- Interpreting multiphase cross-sectional imaging
- Assessing oncologic risk based on tumor characteristics
- Evaluating renal function and CKD staging
- Counseling on all treatment options (partial nephrectomy, radical nephrectomy, thermal ablation, active surveillance)
- Performing or coordinating surgical interventions
When to Involve Additional Specialists
While the urologist leads management, a multidisciplinary team should be included when necessary 1, 2. Specific referrals include:
Nephrology Consultation
Consider referral to nephrology for patients with:
- GFR < 45 mL/min/1.73m²
- Confirmed proteinuria
- Diabetics with preexisting CKD
- Expected post-intervention GFR < 30 mL/min/1.73m² 1
These criteria identify patients at high risk of CKD progression who need specialized renal function management.
Genetic Counseling
Recommend genetic counseling for:
- All patients ≤ 46 years of age
- Patients with multifocal or bilateral renal masses
- Personal or family history suggesting familial renal neoplastic syndrome (von Hippel-Lindau, hereditary papillary RCC, Birt-Hogg-Dubé syndrome) 1, 3
Medical Oncology
For metastatic disease, medical oncology becomes involved for systemic therapy decisions, but the initial evaluation and diagnosis still begins with urology 3.
Common Pitfall to Avoid
Do not delay referral to urology while pursuing extensive workup elsewhere. The urologist should be involved early to coordinate the diagnostic imaging (high-quality multiphase CT or MRI), laboratory evaluation (CMP, CBC, urinalysis), and metastatic evaluation (chest imaging) 1, 2. This ensures proper characterization of the renal mass and appropriate staging from the outset, avoiding redundant testing and treatment delays that could impact outcomes.